Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
595 studies found for:    Open Studies | "Bone Marrow Diseases"
Show Display Options
Rank Status Study
21 Recruiting Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Conditions: Prostate Cancer;   Bone Metastases
Intervention: Drug: [68Ga]P15-041
22 Recruiting A Study to Collect Data About Analgesia in Patients With Bone Metastasis
Condition: Bone Metastasis
Interventions: Other: Questionnaires completion;   Other: Clinical Pain Assessments
23 Recruiting The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones
Condition: Bone Metastasis
Interventions: Procedure: Stabilisation of (impending) pathological fracture;   Radiation: Radiotherapy of bone metastasis
24 Recruiting Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy
Condition: Bone Metastasis
Interventions: Drug: fentanyl transmucosal;   Drug: Placebo
25 Recruiting Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS
Condition: Bone Metastases
Intervention: Radiation: Radiotherapy
26 Recruiting Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Condition: Bone Metastases
Intervention: Other: blood sampling, the SF-36 questionnaire
27 Recruiting Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases
Condition: Bone Metastases
Interventions: Radiation: Conventional Radiotherapy;   Radiation: Biological image-guided radiotherapy with conventional dose.;   Radiation: Biological image-guided SBRT with dose-escalation.
28 Not yet recruiting Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders
Condition: Myeloproliferative Neoplasms
Intervention:
29 Recruiting Italian Network MDS Registry
Condition: Myelodysplastic-Myeloproliferative Diseases
Intervention:
30 Recruiting PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis
Conditions: Primary Myelofibrosis;   Myeloproliferative Disorders
Interventions: Procedure: Allogeneic hematopoietic stem cell transplantation;   Drug: Busulfan;   Drug: Fludarabine monophosphate;   Drug: Cyclophosphamide;   Drug: Ruxolitinib
31 Not yet recruiting Exploring the Mechanisms of Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine Kinase Inhibitors in 3d Model Niche Endosteal
Condition: Myeloproliferative Disorders
Intervention:
32 Recruiting Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)
Conditions: Leukemia;   Lymphoma;   Myeloma;   Myeloproliferative Diseases
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Clofarabine;   Drug: Rabbit ATG;   Radiation: Total Body Irradiation (TBI);   Procedure: Cord Blood Infusions;   Drug: Rituximab;   Drug: Cyclophosphamide;   Procedure: Natural Killer Cell Infusion;   Drug: Melphalan;   Drug: Mesna
33 Recruiting Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
Condition: Myeloproliferative Diseases
Interventions: Drug: Ruxolitinib;   Drug: Pracinostat;   Behavioral: Questionnaire
34 Recruiting Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
Condition: Myeloproliferative Neoplasms
Interventions: Drug: Ruxolitinib;   Drug: Decitabine
35 Recruiting Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Condition: MDS
Interventions: Procedure: Allogeneic Hematopoietic Cell Transplant;   Procedure: Hypomethylating Therapy / Best Supportive Care
36 Recruiting Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms
Condition: Chronic Myeloproliferative Neoplasms
Intervention: Drug: Givinostat
37 Recruiting The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
Conditions: Metastatic Solid Tumor;   Lymphoma;   Myeloproliferative Neoplasms (MPN)
Intervention: Drug: PU-H71
38 Not yet recruiting Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Condition: Severe Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation (TBI);   Procedure: UCB HSCT;   Procedure: Haplo HSCT;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil (MMF);   Drug: G-CSF
39 Not yet recruiting Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Drug: rhTPO;   Drug: placebo
40 Recruiting Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: cyclosporine;   Procedure: Matched Unrelated Donor Hematopoietic Stem Cell Transplant;   Drug: horse anti-thymocyte globulin (ATG);   Drug: rabbit anti-thymocyte globulin (ATG);   Drug: methotrexate;   Drug: fludarabine;   Drug: cyclophosphamide;   Radiation: low-dose total body irradiation (TBI);   Procedure: Immunosuppressive Therapy (IST)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.